Literature DB >> 30466992

Natural products for the prevention and treatment of kidney disease.

Dan-Qian Chen1, He-He Hu1, Yan-Ni Wang1, Ya-Long Feng1, Gang Cao2, Ying-Yong Zhao3.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is one of the common causes resulting in a high morbidity and mortality. Renal fibrosis is the main pathological features of CKD. Natural products have begun to gain widely popularity worldwide for promoting healthcare and preventing CKD, and have been used as a conventional or complementary therapy for CKD treatment.
PURPOSE: The present paper reviewed the therapeutic effects of natural products on CKD and revealed the molecular mechanisms of their anti-fibrosis.
METHODS: All the available information on natural products against renal fibrosis was collected via a library and electronic search (using Web of Science, Pubmed, ScienceDirect, Splinker, etc.).
RESULTS: Accumulated evidence demonstrated that natural products exhibited the beneficial effects for CKD treatment and against renal fibrosis. This review presents an overview of the molecular mechanism of CKD and natural products against renal fibrosis, followed by an in-depth discussion of their molecular mechanism of natural products including isolated compounds and crude extracts against renal fibrosis in vitro and in vivo. A number of isolated compounds have been confirmed to retard renal fibrosis.
CONCLUSION: The review provides comprehensive insights into pathophysiological mechanisms of CKD and natural products against renal fibrosis. Particular challenges are presented and placed within the context of future applications of natural products against renal fibrosis.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Chronic kidney disease; Natural products; Renal fibrosis; TGF-β/Smad; Traditional Chinese medicine

Mesh:

Substances:

Year:  2018        PMID: 30466992     DOI: 10.1016/j.phymed.2018.09.182

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  31 in total

1.  Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy.

Authors:  Yan-Ni Wang; Hao-Yu Feng; Xin Nie; Ya-Mei Zhang; Liang Zou; Xia Li; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

2.  Exploring protective effect of Glycine tabacina aqueous extract against nephrotic syndrome by network pharmacology and experimental verification.

Authors:  Lihua Tan; Yanbei Tu; Kai Wang; Bing Han; Hongquan Peng; Chengwei He
Journal:  Chin Med       Date:  2020-08-01       Impact factor: 5.455

3.  Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/β-Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy.

Authors:  Haoran Dai; Fei Liu; Xinping Qiu; Wenbin Liu; Zhaocheng Dong; Yingmin Jia; Zhendong Feng; Zhiyuan Liu; Qihan Zhao; Yu Gao; Zihan Zhang; Chang Gao; Songge Sun; Xuefei Tian; Baoli Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-03       Impact factor: 2.629

4.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

Review 5.  How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?

Authors:  Zhendong Feng; Wenbin Liu; Han Xue Jiang; Haoran Dai; Chang Gao; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Qihan Zhao; Lei Zhang; Baoli Liu
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

6.  Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis.

Authors:  Lin Chen; Dan-Qian Chen; Jing-Ru Liu; Jun Zhang; Nosratola D Vaziri; Shougang Zhuang; Hua Chen; Ya-Long Feng; Yan Guo; Ying-Yong Zhao
Journal:  Exp Mol Med       Date:  2019-03-27       Impact factor: 8.718

7.  Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics.

Authors:  Xinhui Liu; Shiying Huang; Fochang Wang; Lin Zheng; Jiandong Lu; Jianping Chen; Shunmin Li
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629

8.  Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.

Authors:  Dan-Qian Chen; Gang Cao; Hui Zhao; Lin Chen; Tian Yang; Ming Wang; Nosratola D Vaziri; Yan Guo; Ying-Yong Zhao
Journal:  Ther Adv Chronic Dis       Date:  2019-08-14       Impact factor: 5.091

Review 9.  Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.

Authors:  Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Jing-Ru Liu; Nosratola D Vaziri; Yan Guo; Ying-Yong Zhao
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

Review 10.  Advances of the experimental models of idiopathic membranous nephropathy (Review).

Authors:  Han Xue Jiang; Zhendong Feng; Ze Bing Zhu; Chen Hui Xia; Wenting Zhang; Jing Guo; Bao-Li Liu; Yaoxian Wang; Yu Ning Liu; Wei Jing Liu
Journal:  Mol Med Rep       Date:  2020-03-09       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.